Ken J ISHII

J-GLOBAL         Last updated: Nov 3, 2019 at 00:27
 
Avatar
Name
Ken J ISHII
Alternative names
Ken J. Ishii
URL
http://www.vaccine-science.ims.u-tokyo.ac.jp/
Affiliation
The University of Tokyo
Section
The Institute of Medical Science
Job title
Professor
Degree
M.D., Ph.D.
Other affiliation
Osaka University

Research Areas

 
 

Academic & Professional Experience

 
Apr 2019
 - 
Today
Director, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo
 
Jan 2019
 - 
Today
Professor, Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo
 
Apr 2017
 - 
Dec 2018
Director, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition
 
Apr 2015
 - 
Sep 2015
Director, Center for Drug Design Research, Natioanl Institutes of Biomedical Innvation, Health and Nutrition
 
Apr 2010
 - 
Mar 2015
Project Leader, Lab. Adjuvant Innovation,, National institute of Biomedical innovation (NIBIO)
 

Education

 
 
   
 
Yokohama City University
 
 
 - 
1993
Yokohama City University
 

Awards & Honors

 
Oct 2014
Osaka Science Prize
Winner: ISHII Ken
 

Published Papers

 
Momota M, Lelliott P, Kubo A, Kusakabe T, Kobiyama K, Kuroda E, Imai Y, Akira S, Coban C, Ishii KJ
International immunology      Oct 2019   [Refereed]
Nagatake T, Hirata SI, Koga T, Kuroda E, Kobari S, Suzuki H, Hosomi K, Matsumoto N, Yanrismet Y, Shimojou M, Morimoto S, Sasaki F, Ishii KJ, Yokomizo T, Kunisawa J
Mucosal immunology   12(5) 1082-1091   Sep 2019   [Refereed]
Lee MSJ, Natsume-Kitatani Y, Temizoz B, Fujita Y, Konishi A, Matsuda K, Igari Y, Tsukui T, Kobiyama K, Kuroda E, Onishi M, Marichal T, Ise W, Inoue T, Kurosaki T, Mizuguchi K, Akira S, Ishii KJ, Coban C
European journal of immunology   49(9) 1433-1440   Sep 2019   [Refereed]
Adachi Y, Tonouchi K, Nithichanon A, Kuraoka M, Watanabe A, Shinnakasu R, Asanuma H, Ainai A, Ohmi Y, Yamamoto T, Ishii KJ, Hasegawa H, Takeyama H, Lertmemongkolchai G, Kurosaki T, Ato M, Kelsoe G, Takahashi Y
Nature communications   10(1) 3883   Aug 2019   [Refereed]
Fujimoto K, Kawaguchi Y, Shimohigoshi M, Gotoh Y, Nakano Y, Usui Y, Hayashi T, Kimura Y, Uematsu M, Yamamoto T, Akeda Y, Rhee JH, Yuki Y, Ishii KJ, Crowe SE, Ernst PB, Kiyono H, Uematsu S
Gastroenterology      Aug 2019   [Refereed]
Leach S, Shinnakasu R, Adachi Y, Momota M, Makino-Okamura C, Yamamoto T, Ishii KJ, Fukuyama H, Takahashi Y, Kurosaki T
International immunology      Jun 2019   [Refereed]
Lelliott PM, Momota M, Lee MSJ, Kuroda E, Iijima N, Ishii KJ, Coban C
Cytometry. Part A : the journal of the International Society for Analytical Cytology   95(5) 565-578   Apr 2019   [Refereed]
Yamamoto T, Kanuma T, Takahama S, Okamura T, Moriishi E, Ishii KJ, Terahara K, Yasutomi Y
Scientific reports   9(1) 5917   Apr 2019   [Refereed]
Imanishi T, Unno M, Kobayashi W, Yoneda N, Matsuda S, Ikeda K, Hoshii T, Hirao A, Miyake K, Barber GN, Arita M, Ishii KJ, Akira S, Saito T
Life science alliance   2(1)    Feb 2019   [Refereed]
Yamamoto T, Masuta Y, Momota M, Kanekiyo M, Kanuma T, Takahama S, Moriishi E, Yasutomi Y, Saito T, Graham BS, Takahashi Y, Ishii KJ
International immunology   31(2) 81-90   Feb 2019   [Refereed]

Misc

 
Hiroshi Yokokawa, Hiroshi Yokokawa, Atsunori Higashino, Atsunori Higashino, Saori Suzuki, Saori Suzuki, Masaki Moriyama, Noriko Nakamura, Tomohiko Suzuki, Ryosuke Suzuki, Koji Ishii, Kouji Kobiyama, Kouji Kobiyama, Ken J. Ishii, Ken J. Ishii, Takaji Wakita, Hirofumi Akari, Hirofumi Akari, Takanobu Kato
Gut   67 372-379   Feb 2018
© Published by the BMJ Publishing Group Limited. Objective Although HCV is a major cause of chronic liver disease worldwide, there is currently no prophylactic vaccine for this virus. Thus, the development of an HCV vaccine that can induce both hu...
Nobuo Nishijima, Toshiro Hirai, Toshiro Hirai, Kazuki Misato, Michihiko Aoyama, Etsushi Kuroda, Etsushi Kuroda, Ken J. Ishii, Ken J. Ishii, Kazuma Higashisaka, Yasuo Yoshioka, Yasuo Yoshioka, Yasuo Yoshioka, Yasuo Tsutsumi, Yasuo Tsutsumi
Frontiers in Immunology   8    Apr 2017
© 2017 Nishijima, Hirai, Misato, Aoyama, Kuroda, Ishii, Higashisaka, Yoshioka and Tsutsumi. The application of nanotechnology in the health care setting has many potential benefits; however, our understanding of the interactions between nanopartic...
T. Sugiyama, M. Gursel, F. Takeshita, C. Coban, J. Conover, T. Kaisho, S. Akira, D. M. Klinman, K. J. Ishii
Journal of Immunology   175 2026   Aug 2005
Ken J. Ishii, Ken J. Ishii, Shizuo Akira, Shizuo Akira
Immunity   23 111-113   Aug 2005
CpG methylation of DNA silences TLR9-mediated innate immune recognition. In this issue of Immunity, Kariko et al. (2005) suggest that the innate immune recognition of RNA by TLR3, TLR7, or TLR8 is in fact controlled by modification of nucleotides,...
Yasuo Yoshioka, Yasuo Yoshioka, Yasuo Yoshioka, Yasuo Yoshioka, Etsushi Kuroda, Toshiro Hirai, Yasuo Tsutsumi, Yasuo Tsutsumi, Ken J. Ishii, Ken J. Ishii
Frontiers in Immunology   8    Feb 2017
© 2017 Yoshioka, Kuroda, Hirai, Tsutsumi and Ishii. Over the past decade, a vast array of nanomaterials has been created through the development of nanotechnology. With the increasing application of these nanomaterials in various fields, such as f...

Books etc

 
Ishii, Ken J.
CRC Press   May 2012   
Springer   Jul 2010   ISBN:3642126162

Association Memberships

 
 

Research Grants & Projects

 
Immune response to, and regulation by, extracellular nucleic acids
Japan Science Technology Agency: CREST
Project Year: Oct 2018 - Mar 2024    Investigator(s): ISHII Ken
Nucleic acids, normally reside within cells and work as a blueprint of life; however, recent evidence suggest that nucleic acids can be found outside of cells acting as genetically, epigenetically and immunologically active nanoparticle. We will d...
'Development of a database to evaluate adjuvant safety'
Health Labour Sciences Research Grant: 
Project Year: Apr 2012 - Mar 2017    Investigator(s): Ken J. Ishii
-
Molecular mechanisms of vaccines and adjuvants.
Innate and adaptive immune recognition of nucleic acids